Related Experiment Videos

Deprescribing and medicines optimisation, two sides of the same coin? Considerations for design of interventional

Frank Moriarty¹, Carmel M Hughes²

¹School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Basic & Clinical Pharmacology & Toxicology

|May 14, 2023

Abstract

No abstract available in PubMed .

Keywords:

complex interventions deprescribing medicines optimisation outcome measures polypharmacy

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Recruitment and retention of older people with dementia in clinical trials focused on evaluating the pharmacological management of the cognitive symptoms of dementia: a scoping review.

The International journal of pharmacy practice·2026

The prevalence and impact of medication-related harm in people living with dementia - a systematic review and meta-analysis.

Research in social & administrative pharmacy : RSAP·2026

Hospital pharmacists' knowledge about and attitudes towards dementia: a cross-sectional survey study.

The International journal of pharmacy practice·2026

Identification of Potentially Inappropriate Medications for Adults Below 65 Years: Protocol for a Modified Delphi Study.

JMIR research protocols·2026

Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support Deprescribing.

Clinical pharmacology and therapeutics·2026

An ageing biomarker signature predicts chronic disease cluster trajectories, physical function and mortality: validation in the TILDA and HRS cohorts.

Age and ageing·2026

See all related articles